enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. IQVIA - Wikipedia

    en.wikipedia.org/wiki/IQVIA

    [28] [29] IMS Health shareholders received 0.384 shares of Quintiles common stock for each share of IMS Health common stock they held, leaving the split of ownership at 51.4% IMS and 48.6% Quintiles. [ 30 ] [ 31 ] The merger was completed in October and the resulting company was a $17.6 billion company called QuintilesIMS. [ 9 ]

  3. IMS Health - Wikipedia

    en.wikipedia.org/wiki/IMS_Health

    IMS stood for Intercontinental Medical Statistics. It was the largest vendor of U.S. physician prescribing data. [2] [3] [4] IMS Health was founded in 1954 by Bill Frohlich and David Dubow with Arthur Sackler having a hidden ownership stake. [5] In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green ...

  4. Quintiles Rated Industry Leader and Highest in Service ... - AOL

    www.aol.com/2013/05/21/quintiles-rated-industry...

    For premium support please call: 800-290-4726 more ways to reach us

  5. Quintiles Named a Best Workplace in Europe - AOL

    www.aol.com/2013/06/28/quintiles-named-a-best...

    Quintiles Named a Best Workplace in Europe Ranked 8th in the Best "Multinational Large" Workplace category RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Quintiles announced today that it has ...

  6. Quintiles Named a "Best Place to Work in IT" by ... - AOL

    www.aol.com/news/2013-06-18-quintiles-named-a...

    For premium support please call: 800-290-4726 more ways to reach us

  7. Organ harvesting from Falun Gong practitioners in China

    en.wikipedia.org/wiki/Organ_harvesting_from...

    Data compiled by American company Quintiles IMS showed China's share of global demand for immunosuppressant drugs, which are necessary to prevent the bodies of patients from rejecting transplanted organs, were approximately in line with the proportion of global transplants China said it performed. [8]

  8. John L. Clendenin - Pay Pals - The Huffington Post

    data.huffingtonpost.com/paypals/john-l-clendenin

    From January 2008 to May 2009, if you bought shares in companies when John L. Clendenin joined the board, and sold them when he left, you would have a -3.9 percent return on your investment, compared to a -38.2 percent return from the S&P 500.

  9. Quintiles to Acquire Novella Clinical - AOL

    www.aol.com/2013/08/14/quintiles-to-acquire...

    Quintiles to Acquire Novella Clinical Acquisition bolsters Quintiles' small biopharma, oncology and medical device capabilities RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- To stay ahead of the ...